depression and tirzepatide What are the considerations for using (a glucagon-like peptide-1 (GLP-1) receptor agonist) with fluvoxamine (a selective serotonin reuptake inhibitor (SSRI)) in a patient with type 2 diabetes or anxiety? Does Zepbound (tirzepatide) cause depression?

People with SLE have around two to three times the coronary artery disease risk of the general population, driven partly by accelerated atherosclerosis (narrowing of the arteries)

1 Figure 1 shows the numerous physiological effects of GLP-1 agonists, affecting a wide range of systems including the brain, muscle, pancreas, liver and heart

Where the diagnosis is uncertain, hair loss is persistent, or scarring alopecia is suspected, referral to NHS dermatology is the appropriate pathway

In people with type 2 diabetes, semaglutide helps lower blood sugar levels by stimulating insulin secretion and inhibiting glucagon production